Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2024

Summary of Significant Accounting Policies [Abstract]

Schedule of Continuing Operations, Assets and Liabilities Split

The following is a summary of the Company’s continuing operations, assets and liabilities split between the Unites States and Canada:

	United States			Canada			Total
Expenses	$	3,468,907		$	194,659		$	3,663,566
Other income (expense)		(353,148	)		-			(353,148	)
Net loss from continuing operations	$	3,822,055		$	194,659		$	4,016,714
Current Assets	$	4,826,296		$	31,897		$	4,858,193
Non-current assets		2,941,078			1,086			2,942,164
Total Assets	$	7,767,374		$	32,983		$	7,800,357
Current liabilities	$	1,238,243		$	11,975		$	1,250,218
Non-current liabilities		534,467			-			534,467
Total Liabilities	$	1,772,710		$	11,975		$	1,784,685
Total Equity	$	7,255,391		$	(595,827	)	$	6,659,564

Schedule of Estimated Useful Lives of Intangible Assets

The estimated useful lives of intangible assets are generally as follows:

License #1 – INmune	10-year straight-line
License #2 – MOA	IPR&D project not yet complete

Schedule of Useful Lives of Property and Equipment

The estimated useful lives of property and equipment are generally as follows:

Lab equipment	7-year straight-line
Furniture and fixtures	7-year straight-line
Computers	5-year straight-line

Schedule of Derivative Liabilities

	Level 1		Level 2		Level 3		Total
December 31, 2024:
Cash	$	3,984,453	$	-	$	-	$	3,984,453
Investment in securities		-		139,084		-		139,084
Derivative liabilities		-		-		-		-
	$	3,984,453	$	139,084	$	-	$	4,123,537
December 31, 2023:
Cash	$	3,326,851	$	-	$	-	$	3,326,851
Derivative liabilities		-		-		369,158		369,158
	$	3,326,851	$	-	$	369,158	$	3,696,009